Wyeth Provides Status Update On TRIPHASIL-28 And ALESSE Oral Contraceptives
Mon, 07 Aug 2006 06:00 AM EST
... Wyeth (NYSE:WYE) announced that the company has designated both TRIPHASIL®-28 (levonorgestrel and ethinyl estradiol tablets-triphasic regimen) and ALESSE® (0.1 mg levonorgestrel/0.02 mg ethinyl estradiol tablets) oral contraceptives as temporarily out of stock (TOS). This TOS designation means that Wyeth is unable to re-supply these oral contraceptives. [click link for full article] ...
Related Topics
- Ethinyl Estradiol and Levonorgestrel
- Oral Contraceptives
- Oral Cancer
- Ethinyl Estradiol and Norgestrel
- Confusion and changes in mental status may develop if the condition is not treated.
- Oral Health
- Amoxicillin Oral Suspension
- Drospirenone and Ethinyl Estradiol
- Zidovudine Oral Syrup
- Bismuth Subsalicylate Oral Liquid
- Sumatriptan Oral
- Ergocalciferol, Vitamin D2 Oral Solution
- Stavudine Oral Solution
- Metronidazole Oral
- Erythromycin Oral Suspension
- Fluconazole Oral
- Terbinafine Oral
- Methadone Oral
- Mesoridazine Oral Concentrate
- Pseudoephedrine and Hydrocodone

Not Signed In -

